(7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one

C48H60N16O4 — CID 158536648

IUPAC(7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one
SMILESC[C@@H]1CN(c2cnc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2[C@@H](C)CCCO3)CCN1C.C[C@H]1CN(c2cnc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2[C@@H](C)CCCO3)CCN1C
InChIInChI=1S/2C24H30N8O2/c2*1-16-6-5-11-34-24-19(12-18(13-25-24)31-10-9-30(3)17(2)14-31)23(33)28-21-8-4-7-20(27-21)22-29-26-15-32(16)22/h2*4,7-8,12-13,15-17H,5-6,9-11,14H2,1-3H3,(H,27,28,33)/t16-,17+;16-,17-/m00/s1
InChIKeyHOAGJVFSTXXHDL-MXPMIKLKSA-N
MW925.12 g/mol
LogP5.72
Rot. Bonds2

About (7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one

(7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one (PubChem CID 158536648) has the molecular formula C48H60N16O4 and a molecular weight of 925.12 g/mol. Its IUPAC name is (7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one.

Molecular Properties

Compound Name(7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one
PubChem CID158536648
Molecular FormulaC48H60N16O4
Molecular Weight925.12 g/mol
Exact Mass924.50
IUPAC Name(7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one
SMILESC[C@@H]1CN(c2cnc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2[C@@H](C)CCCO3)CCN1C.C[C@H]1CN(c2cnc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2[C@@H](C)CCCO3)CCN1C
InChIInChI=1S/2C24H30N8O2/c2*1-16-6-5-11-34-24-19(12-18(13-25-24)31-10-9-30(3)17(2)14-31)23(33)28-21-8-4-7-20(27-21)22-29-26-15-32(16)22/h2*4,7-8,12-13,15-17H,5-6,9-11,14H2,1-3H3,(H,27,28,33)/t16-,17+;16-,17-/m00/s1
InChIKeyHOAGJVFSTXXHDL-MXPMIKLKSA-N
XLogP5.72
TPSA202.60 Ų
H-Bond Donors2
H-Bond Acceptors18
Rotatable Bonds2
Heavy Atoms68
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500925.12
LogP ≤ 55.72
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1018

Analyze (7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one?
The IUPAC name of (7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one (CID 158536648) is (7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one.
What is the SMILES notation for (7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one?
The canonical SMILES for (7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one is C[C@@H]1CN(c2cnc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2[C@@H](C)CCCO3)CCN1C.C[C@H]1CN(c2cnc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2[C@@H](C)CCCO3)CCN1C.
What is the InChIKey of (7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one?
The InChIKey is HOAGJVFSTXXHDL-MXPMIKLKSA-N. The full InChI is InChI=1S/2C24H30N8O2/c2*1-16-6-5-11-34-24-19(12-18(13-25-24)31-10-9-30(3)17(2)14-31)23(33)28-21-8-4-7-20(27-21)22-29-26-15-32(16)22/h2*4,7-8,12-13,15-17H,5-6,9-11,14H2,1-3H3,(H,27,28,33)/t16-,17+;16-,17-/m00/s1.
What are the key properties of (7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one?
(7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one has a molecular weight of 925.12 g/mol, XLogP of 5.72, 2 rotatable bonds, 2 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for (7S)-15-[(3S)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(7S)-15-[(3R)-3,4-dimethylpiperazin-1-yl]-7-methyl-11-oxa-3,4,6,13,19,24-hexazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one is sourced from PubChem (CID 158536648), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).